Akums is known for developing new formulations, undertaking bioequivalence studies, and clinical trials, and obtaining the Drug Controller General of India’s (DCGI) approval for manufacturing and marketing of new Fixed Dose Combinations (FDCs) & molecules. Akums also offers new formulations developed with Akums’s technology to its customers under their brand names. Akums also manufactures innovative and technology-driven products
Contract Research & Manufacturing Services (CRAMS)
Technology Transfer
Loan License
Contract Development
Novel Drug Delivery systems (N.D.D.S)
Novel / 1st time launches in India with DCGI Approvals
Technical Collaboration & Joint Venture